Ranjan J. Perera

hopkinsmedicine.org/news/newsroom/… cell.com/cell-reports/f…

Investigators @hopkinskimmel may soon be able to differentiate Group 4 medulloblastomas (brain tumors) in children from more aggressive Group 3 using a long noncoding RNA that could lead to better-targeted treatments. hopkinsmedicine.org/news/newsroom/… via @HopkinsMedNews

We have post-doc positions open for a newly funded NIH R01 grant to study lncRNA therapeutics in cancer at the Johns Hopkins University at Perera lab. Please apply jperera2@jh.edu

@USAmbSLM Just ran into this by accident. Curious to know what does the name Annapurna means?

Join me in May for the @KeystoneSymp virtual #eSymposia, #NonCodingRNA: Biology and Applications, to explore emerging research on #lncRNA and network with global experts on interactive platforms. Register now keysym.us/VKSNonCodingRN… #VKSNonCodingRNA21

"Long non-coding RNAs in brain tumors" Keisuke Katsushima, George Jallo, Charles G Eberhart, Ranjan J Perera lnkd.in/dp5dHnF

Biomarker of Aggressive Childhood Cancer Discovered hopkinsmedicine.org/news/newsroom/…

academic.oup.com/neuro-oncology… Novel lncRNA RNA HLX2-7 in medulloblastoma by Katsushima et al., in Perera lab.

Post-doc position to study long noncoding RNAs in medulloblastoma- Perera and Jallo laboratory at the Johns Hopkins University SOM and Center for RNA Biology at the JHACH is looking for a post-doc to study lncRNAs in MB. Please pass the message contact-jperera2@jhu.edu

A postdoctoral fellow position is open in the Perera laboratory at the Department of Oncology, Johns Hopkins University School of Medicine, and Center for RNA Biology. email - jperera2@jhu.edu Thanks-

@longnoncoding Looking for a post-doc if anyone can help. Thanks Postdoctoral Fellow Position in Cell and Molecular Biology (Oncology & Non-coding RNA Research). contact - jperera2@jhu.edu

bioanalysis-zone.com/2020/02/28/uri… newswise.com/articles/resea… nature.com/articles/s4159…

@StevenSalzberg1 @wolfejosh agree totally

@wolfejosh false premise here. First off, there are far fewer HHMI investigators; 2nd, most of them were NIH-funded before getting HHMI funding. HHMI can 'skim the cream'; on average this means their grantees may seem to do better, but plenty of NIH-funded scientists in the same league

A few simple + key reasons that HHMI investigators innovate way more w/big breakthroughs than NIH grant recipients w/incremental ones The incentive for the former: EXPLORE; the latter EXPLOIT. (Lux loves to back HHMI folks + has 2 VERY exciting new stealth projects underway)

moving to Johns Hopkins starting from July 1st

Bionano Saphyr will definitely revolutionize the cytogenetics in near future. bionanogenomics.com/products/saphy…

Luise DeStefano-